XML 98 R79.htm IDEA: XBRL DOCUMENT v3.23.1
Discontinued operations (Details 3) - BRL (R$)
R$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Discontinued operations      
Net revenue R$ 143,634,708 R$ 109,732,842 R$ 74,058,056
Cost of products and services sold (136,276,257) (104,827,966) (70,056,447)
Gross profit 7,358,451 4,904,876 4,001,609
Operating income (expenses)      
Operating income (loss) 3,336,752 1,787,014 1,545,960
Share of profit (loss) of subsidiaries, joint ventures and associates 12,181 (17,634) (44,031)
Operating income before financial income (expenses) and income and social contribution taxes 3,348,933 1,769,380 1,501,929
Financial result, net (1,469,208) (762,732) (550,348)
Income (loss) before income and social contribution taxes 1,879,725 1,006,648 951,581
Income and social contribution taxes (341,514) (188,034) (304,517)
Net income from continuing operations 1,538,211 818,614 647,064
Net income from discontinued operations 301,858 65,264 280,633
Profit (loss) for the year 1,840,069 883,878 927,697
Depreciation and amortization for the year 1,525,567 1,196,355 1,127,637
Net cash provided by (used in) operating activities 1,974,144 1,603,441 2,264,013
Net cash used in investing activities 8,123,291 882,869 (1,649,015)
Net cash provided by (used in) financing activities (6,731,716) (2,802,574) 327,351
Elimination of intersegment amounts [member]      
Discontinued operations      
Net revenue (272,574) (214,715) (193,046)
Cost of products and services sold 266,122 194,118 133,384
Gross profit (6,452) (20,597) (59,662)
Operating income (expenses)      
Operating income (loss) 0 0 0
Share of profit (loss) of subsidiaries, joint ventures and associates 0 0 0
Operating income before financial income (expenses) and income and social contribution taxes 0 0 0
Depreciation and amortization for the year (346) 0 0
Total Discontinued operations      
Discontinued operations      
Net revenue 3,267,533 9,065,795 7,183,046
Cost of products and services sold (2,485,069) (6,901,181) (5,571,767)
Gross profit 782,464 2,164,614 1,611,279
Operating income (expenses)      
Selling marketing and administrative     (1,493,238)
Other operating income, net     148,054
Operating income (loss) 388,608 98,885 266,095
Share of profit (loss) of subsidiaries, joint ventures and associates     414
Operating income before financial income (expenses) and income and social contribution taxes 388,377 98,933 266,509
Financial result, net 52,525 (146,970) 280,974
Income (loss) before income and social contribution taxes 440,902 (48,037) 547,483
Income and social contribution taxes     (266,850)
Net income from continuing operations     0
Net income from discontinued operations 301,858 65,264 280,633
Profit (loss) for the year     280,633
Depreciation and amortization for the year   463,414 [1] 428,962 [2]
Net cash provided by (used in) operating activities     874,106
Net cash used in investing activities     (487,390)
Net cash provided by (used in) financing activities     (919,684)
Effect of exchange rate changes on cash and cash equivalents in foreign currency     114,822
Increase (decrease) in cash and cash equivalents (387,981) 327,372 (418,146)
Total Discontinued operations | Oxiteno S. A. Industria e Comercio [member]      
Discontinued operations      
Net revenue 2,039,287 7,102,771 5,210,704
Cost of products and services sold (1,580,000) (5,540,773) (4,188,711)
Gross profit 459,287 1,561,998 1,021,993
Operating income (expenses)      
Selling marketing and administrative     (831,056)
Other operating income, net     153,457
Operating income (loss) 268,658 610,701 344,394
Share of profit (loss) of subsidiaries, joint ventures and associates     414
Operating income before financial income (expenses) and income and social contribution taxes 268,427 610,749 344,808
Financial result, net 23,153 (431,441) 1,482
Income (loss) before income and social contribution taxes 291,580 179,308 346,290
Income and social contribution taxes     (118,132)
Net income from continuing operations     0
Net income from discontinued operations 326,028 249,303 0
Profit (loss) for the year     228,158
Depreciation and amortization for the year   308,564 [1] 275,063 [2]
Net cash provided by (used in) operating activities     765,090
Net cash used in investing activities     (159,349)
Net cash provided by (used in) financing activities     (1,236,490)
Effect of exchange rate changes on cash and cash equivalents in foreign currency     114,822
Increase (decrease) in cash and cash equivalents (334,892) (104,160) (515,927)
Total Discontinued operations | Extrafarma [member]      
Discontinued operations      
Net revenue 1,235,487 1,986,932 1,988,411
Cost of products and services sold (912,310) (1,384,316) (1,399,125)
Gross profit 323,177 602,616 589,286
Operating income (expenses)      
Selling marketing and administrative     (662,182)
Other operating income, net     (5,403)
Operating income (loss) (121,375) (511,816) (78,299)
Share of profit (loss) of subsidiaries, joint ventures and associates     0
Operating income before financial income (expenses) and income and social contribution taxes (121,375) (511,816) (78,299)
Financial result, net (25,059) (45,265) (38,938)
Income (loss) before income and social contribution taxes (146,434) (557,081) (117,237)
Income and social contribution taxes     (40,453)
Net income from continuing operations     0
Net income from discontinued operations (98,524) (401,665) 0
Profit (loss) for the year     (157,690)
Depreciation and amortization for the year   154,850 [1] 153,899 [2]
Net cash provided by (used in) operating activities     111,396
Net cash used in investing activities     (6,484)
Net cash provided by (used in) financing activities     11,272
Effect of exchange rate changes on cash and cash equivalents in foreign currency     0
Increase (decrease) in cash and cash equivalents (53,108) (33,059) 116,184
Total Discontinued operations | Elimination of intersegment amounts [member]      
Discontinued operations      
Net revenue (7,241) [3] (23,908) [4] (16,069)
Cost of products and services sold 7,241 [3] 23,908 [4] 16,069
Gross profit 0 [3] 0 [4] 0
Operating income (expenses)      
Selling marketing and administrative     0
Other operating income, net     0
Operating income (loss) 0 [3] 0 [4] 0
Share of profit (loss) of subsidiaries, joint ventures and associates     0
Operating income before financial income (expenses) and income and social contribution taxes 0 [3] 0 [4] 0
Financial result, net 54,431 [3] 329,736 [4] 318,430
Income (loss) before income and social contribution taxes 54,431 [3] 329,736 [4] 318,430
Income and social contribution taxes     (108,265)
Net income from continuing operations     0
Net income from discontinued operations 35,924 [3] 217,626 [4] 0
Profit (loss) for the year     210,165
Depreciation and amortization for the year   0 [1],[4] 0 [2]
Net cash provided by (used in) operating activities     (2,380)
Net cash used in investing activities     (321,557)
Net cash provided by (used in) financing activities     305,534
Effect of exchange rate changes on cash and cash equivalents in foreign currency     0
Increase (decrease) in cash and cash equivalents R$ 19 R$ 464,591 R$ (18,403)
[1] Balances included for a complete breakdown of segment information.
[2] Balances included for complete breakdown of segment information.
[3] Elimination between continuing and discontinued operations related to the interest on the intercompany loan between Ultrapar International and Oxiteno.
[4] Elimination between the continued operations and discontinued operations related to loan between Ultrapar International and Oxiteno.